Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advances in Surgery|August 5, 2026
Watch and Wait in Patients with Clinical Complete Response After Neoadjuvant Therapy with Rectal Cancer: Is it Safe?Bryan Szeglin, John Migaly
Advances in Surgery|August 5, 2026
Total Neoadjuvant Therapy for the Treatment of Locally Advanced Rectal CancerBryan Szeglin, John Migaly
Egastroenterology|January 8, 2024
Pioneering use of genetic analysis for CDH1 to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancerFarzad Mokhtari-Esbuie, Bryan Szeglin, Mohsen Rouhani Ravari, et al.
Molecular Cancer|August 3, 2018
MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signalingSrijayaprakash Babu Uppada, Saiprasad Gowrikumar, Rizwan Ahmad, et al.
Human Brain Mapping|June 3, 2015
Test-retest reliability of freesurfer measurements within and between sites: Effects of visual approval processZafer Iscan, Tony B Jin, Alexandria Kendrick, et al.
Molecular Oncology|April 5, 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrixJin K Kim, Michael R Marco, Seo-Hyun Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant ChemotherapyAndrea Cercek, Gustavo Dos Santos Fernandes, Campbell S Roxburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and ChemoresistanceIsaac Wasserman, Lik Hang Lee, Shuji Ogino, et al.
Pageof 1